Pinned Tweet
Triall and MayoClinic to advance blockchain technology in clinical trials
We are proud to share that @MayoClinic will onboard Triall's #blockchain-integrated #eClinical platform in a #clinicaltrial that includes 10 sites and 500+ patients across the US.
finance.yahoo.com/triall-adv…
LBank de-listing announcement
In light of Triall’s company closing, $TRL will be de-listed from @LBank_Exchange at 12:00 UTC on March 4, 2024.
Please cancel your pending orders. For those who do not actively cancel, LBank will cancel them uniformly.
support.lbank.com/hc/en-gb/a…
MEXC de-listing announcement 📢
In light of Triall’s company closing, $TRL will be de-listed from @MEXC_Official on March 2, 2024.
Please withdraw your assets in time to avoid any asset losses.
👇 More info on deposits, trading, and withdrawals:
mexc.com/support/articles/17…
Community announcement 📢
Dear Triall community,
Today, we regretfully must inform you that Triall will be closing its business operations.
👇 Read the full message
t.me/triallofficial/592
Community announcement 📢
Dear Triall community,
It is with a heavy heart that we must inform you about challenges Triall is facing in light of ongoing economic headwinds.
👉 Read the full message: t.me/triallofficial/590
#TRLInsights - 55% of sponsors & CROs report using RBQM in their #clinicaltrials.
78% trust that #RBQM improves study quality, while 64% believe RBQM increases efficiency & cost savings, and 53% trust it can reduce timelines.
Source: csdd.tufts.edu/impact-report…
#DeSci #TRL
5 key areas for reporting & analytics in clinical trials 👩💻
eClinical tech continues to open up new avenues for reporting & analytics, promoting #clinicaltrial quality, efficiency & adaptability.
👇🧵Here are 5 critical areas for reporting & analytics enabled by #eClinical:
And that's a wrap!
Want to empower your studies with the latest reporting & analytics features? Our eClinical platform supports all of these 5 capabilities.
Reach out to our team at [email protected] for more info.
#blockchainforhealth #TRL #DeSci
#TRLInsights - According to @TuftsCSDD, a typical Phase III #clinicaltrial conducted during 2016-2021 included an average of 25.8 endpoints.
This number is 37% higher compared to 2015, signalling a sharp increase in clinical trial complexity.
Source: csdd.tufts.edu/impact-report…
#TRLInsights - 1 in 3 participants do not feel valued for their contribution to clinical research.
This can impact retention, satisfaction & overall adherence.
@TranscelerateB has therefore developed a best practices #Gratitude #Toolkit.
👉 Source: transceleratebiopharmainc.co…
⏩ Auto-validation ⏩
Study builders are increasingly using auto-validation simulators to validate their eCRFs against preprogrammed edit checks. This ensures data does not need to be entered by hand and often also auto-generates validation reports for future reference.
⏩ Payments ⏩
Sites and participants often need to wait months before being compensated. Modern eClinical platforms tackle this issue by enabling automated payments based on completed study tasks & milestones, ensuring accurate & timely payment of key contributors.
And that’s a wrap!
Want to future-proof your clinical trials?
Our eClinical platform supports all of the above workflow automation capabilities. Reach out to our team at [email protected] for more info.
#blockchainforhealth #TRL #DeSci
⏩ Direct data capture ⏩
Solutions such as eSource, ePRO, eConsent, and wearables allow data to directly flow into the EDC database. This eliminates the need to manually transcribe data from a paper chart or EHR, thereby promoting speed and lowering #SDV requirements.
5 key automations in clinical trials 🤖
One of the most promising benefits of modern #eClinical solutions is their power to #automate manual, time-consuming, and error-prone study tasks.
👇🧵 Here are 5 promising areas for workflow automation in #clinicaltrials and #DeSci:






